Oxford Biomedica Share Discussion Threads

[harry s truman] 04/10/2022 11:53

Good luck with it seanje.

I have a feeling that we are due news which will make this a very shrewdly timed investment of yours, and obviously I hope very much that it is.

[seanje] 04/10/2022 11:49

Morning all. For the record, I came into a small nest egg recently and have today, made a reasonable purchase because I entirely accord with Tucos view that there is every probability of a quick turnaround here. We shall see, but I think this is a ludicrously low valuation. I am prepared to wait but come what may, I believe the story. And by the way, my purchase does not show on ADVFN. Good luck all.

[tuco 1] 04/10/2022 09:20

Of course , there does need to be a buyer !
So far only about £30 thousand pounds of shares traded . That would possibly buy you a kennel in Hartlepool .

Tuco.

[tuco 1] 04/10/2022 08:22

Two words- " Coiled spring "

This could be a quite spectacular bounce from here if there is any meaningful institutional buying . I think any forced or stale sellers are now out .

Tuco.

[ibby5] 03/10/2022 22:38

Harry mate the thread you mentioned 17 sept 2022( Hey badger good to have you back mate ) if you read between the lines you will see I was taken the Pi.s rather than complementing him on his article's.
Having said all that it's always good to have a different point of view on oxb but sadly in badgers case he continues to play the same record repeating the same information.

[pezza51053] 03/10/2022 19:12

Totally agree and they have the subtlety of a sledgehammer - quite sad life for them really😎

[harry s truman] 03/10/2022 19:00

No worries pezza.

We do have some very interesting fellow travellers and I remain convinced that more than a few of them are the same person.

[pezza51053] 03/10/2022 18:55

HST - I think we are both on the same page

[pezza51053] 03/10/2022 18:45

No probs Ibby - I wouldn’t worry about SII as they are about to make an even greater reputation on making rather a lot of serum for Malaria and Ebola jabs - they might need a bit of help with that too and prudently they have reserved a lot of processing facility for that - hear’s to OXB👍

[harry s truman] 03/10/2022 18:44

pezza,

When ibby first turned up as an "account created on the day" / "first post long term holder", I thought this has bored Badger written all over it it.

ibby assured me I was wrong, so benefit of the doubt and all that. Have you clicked on the post history today?

ibby5 - 17 Sep 2022 - 18:12:42 - 426 of 433 OXB - sense and sensibility - OXB

Hey badger good to have you back mate, I definitely missed your invaluable comments on oxb welcome back man, I was just telling the other guys you haven't contributed on this forum for a while now and I mentioned that you probably took a flight to India to let the serum institute of India board know how they wasted 50m of their money on Oxford biomedical and the last laugh is on them, man they should have been listening to you, I bet they will listen to you from now on and probably asked you if you can join their board so you can prevent them from making the same mistake again.

Keep flying the British flag body. From a secret admirer....

[ibby5] 03/10/2022 18:33

Thanks Pezza I have corrected my mistakes.
All the same it now feels like it can't get any worse and hopefully the share price is on its way up, although having said all that I am sure bodger will correct me by reminding me how much money the serum institute of India have lost and our bad investment in the US.

[pezza51053] 03/10/2022 17:57

Ibby - Do you mean ‘quiet’ or ‘quit’ - Oh and by the way his names Bodger (the master baiter) not Dodger and he’s famous for getting a personal ‘grip’ on matters in private

[ibby5] 03/10/2022 16:41

Come across this information guy's. ( The last 12 months of insider transactions at Oxford biomedical ) the biggest single purchase by an insider was when interim CEO @ chairman Roch Doliveux bought £343k worth of shares at £5.89 per share, this suggests that he is bullish about the company, well guys let's hope he knows something that we don't and his faith in the company can quiet our one and only non investor Mr bodger 😜 don't forget mate I am your only secret admirer on this forum.

[harry s truman] 03/10/2022 15:41

A lot of vector work for someone Marcus, and back to what they said at the interims about OXB being contacted by people let down by the promises / efforts of others.

Anyway, if this takeover of a much smaller vector player means we close blue for a little while until some more news of our own comes, then I'm fine with that.

[marcusl2] 03/10/2022 15:34

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of LogicBio Therapeutics, Inc. (NASDAQ: LOGC) to AstraZeneca Rare Disease for $2.07 per share is fair to LogicBio shareholders.


Possibly H, anyway, yet more uses for Car T which is good news.

[harry s truman] 03/10/2022 15:28

Honestly don't know the history here Marcus, but I'm pretty certain a board recommendation can only come if they decide over a meeting that the bid is the best option for shareholders - so I guess it must be.

[marcusl2] 03/10/2022 15:14

Maybe AZ is under-paying? $4 a year ago, $17 at peak in 2018.






Dangerous fungal lung infections could be treated with CAR T-cells


To test if the approach worked for the fungus, the team exposed mice with suppressed immune systems to A. fumigatus. The group then treated some mice with the CAR T-cells a day later and left the other mice untreated.

Two weeks after initial exposure to the fungus, 80 per cent of mice treated with CAR T-cells survived, while just 33 per cent of untreated mice were alive

[harry s truman] 03/10/2022 14:19

What LogicBio Therapeutics Inc shareholders need now is for our constructive criticism crew to give them a summary of all the things wrong with Astra's plan.

[harry s truman] 03/10/2022 14:17

AstraZeneca Plc's (NASDAQ: NASDAQ:AZN) subsidiary, Alexion (NASDAQ:ALXN), has agreed to acquire LogicBio Therapeutics Inc (NASDAQ: LOGC) for $2.07 per share. Both boards have unanimously approved the transaction.

Alexion plans to close the deal in four to six weeks, subject to the tender of at least a majority of the outstanding shares of LogicBio common stock.

It plans to retain LogicBio employees at their current location.


The proposed acquisition brings LogicBio's unique technology, experienced rare disease R&D team, and expertise in pre-clinical development to support Alexion's growth in genomic medicines.

Fred Chereau, President and Chief Executive Officer, LogicBio, said, "Through this acquisition, we strive to accelerate our research in gene editing and AAV capsid development and together move the field of genomic medicine forward."

LogicBio has developed technology platforms for the delivery and insertion of genes to address genetic diseases and a platform designed to improve viral vector manufacturing processes.

Price Action: LOGC shares are up 633.9% at $2.00 during the premarket session on the last check Monday.

[harry s truman] 03/10/2022 14:15

Thanks for that rrb - LOGC shares are up 633.9% at $2.00 during the premarket session on the last check Monday.

Interesting premium for a company with 63 employees and revenue of $3m

So the equivalent for us would be £3.59 x 6.339 = £22.75 which is still short of the high analyst target.

[rrb] 03/10/2022 12:49

Astra buying LogicBio - gene therapy vector developer. Wonder if that brings any buyers to OXB. Largest lentivector manufacturer. Cheap level to acquire?